Obesity and Multiple Sclerosis: A Mendelian Randomization Study

PLoS Medicine

Volumn 13, Issue 6, 2016, Pages

  Mokry, Lauren E ^a,b   Ross, Stephanie ^b   Timpson, Nicholas J ^c   Sawcer, Stephen ^d   Davey Smith, George ^c   Richards, J Brent ^a,b,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d King's College London ^*  (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; MENDELIAN RANDOMIZATION ANALYSIS; MULTIPLE SCLEROSIS; OBESITY; PLEIOTROPY; PREVALENCE; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; GENETICS; ODDS RATIO;

BODY MASS INDEX; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; MULTIPLE SCLEROSIS; OBESITY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84978173207     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002053     Document Type: Article

References (56)

1. Compston A, Coles A, Multiple sclerosis. Lancet. 2008;372: 1502–1517. doi: 10.1016/S0140-6736(08)61620-718970977
2. Trisolini M, Honeycutt A, Wiener J, Lesesne S. MS International Federation. In: Global Economic Impact of Multiple Sclerosis. 2010 [cited 21 Apr 2016]. http://www.msif.org/wp-content/uploads/2014/09/Global_economic_impact_of_MS.pdf
3. Hartung DM, Bourdette DN, Ahmed SM, Whitham RH, The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?Neurology. 2015;84: 2185–2192. doi: 10.1212/WNL.000000000000160825911108
4. Munger KL, Chitnis T, Ascherio A, Body size and risk of MS in two cohorts of US women. Neurology. 2009;73: 1543–1550. doi: 10.1212/WNL.0b013e3181c0d6e019901245
5. Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sørensen TIA, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013;19: 1323–1329. doi: 10.1177/135245851348388923549432
6. Hedstrom a. K, Olsson T, Alfredsson L, High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler J. 2012;18: 1334–1336. doi: 10.1177/1352458512436596
7. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289: 1799–804. doi: 10.1001/jama.289.14.179912684358
8. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB, Low-Grade Systemic Inflammation in Overweight Children. Pediatrics. 2001;107: e13. 11134477
9. Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, Tybjærg-Hansen A, et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes. 2011;35: 300–308. doi: 10.1038/ijo.2010.137
10. Würtz P, Wang Q, Kangas AJ, Richmond RC, Skarp J, Tiainen M, et al. Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med. 2014;11: e1001765. doi: 10.1371/journal.pmed.100176525490400
11. van Dielen FM, van’t Veer C, Schols AM, Soeters PB, Buurman WA, Greve JW, Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord. 2001;25: 1759–1766. doi: 10.1038/sj.ijo.080182511781755
12. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association Between Adiponectin and Mediators of Inflammation in Obese Women. Diabetes. 2003;52: 942–947. doi: 10.2337/diabetes.52.4.94212663465
13. Davey Smith G, Ebrahim S, “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease?Int J Epidemiol. 2003;32: 1–22. 12689998
14. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365: 1876–1885. doi: 10.1056/NEJMoa101011222087679
15. Reilly JJ, Kelly J, Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes (Lond). 2011;35: 891–898. doi: 10.1038/ijo.2010.222
16. Barlow SE, Dietz WH, Management of child and adolescent obesity: summary and recommendations based on reports from pediatricians, pediatric nurse practitioners, and registered dietitians. Pediatrics. 2002;110: 236–238. 12094001
17. Goodin DS, The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol. 2014;122: 231–266. doi: 10.1016/B978-0-444-52001-2.00010-824507521
18. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518: 197–206. doi: 10.1038/nature1417725673413
19. Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45: 1353–1360. doi: 10.1038/ng.277024076602
20. Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476: 214–219. doi: 10.1038/nature1025121833088
21. Walter K, Min JL, Huang J, Crooks L, Memari Y, McCarthy S, et al. The UK10K project identifies rare variants in health and disease. Nature. 2015;526: 82–90. doi: 10.1038/nature1496226367797
22. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O’Donnell CJ, De Bakker PIW, SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24: 2938–2939. doi: 10.1093/bioinformatics/btn56418974171
23. SNAP Proxy Search. In: Broad Institute. 2016 [cited 21 Apr 2016]. https://www.broadinstitute.org/mpg/snap/ldsearch.php
24. Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G, Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27: 1133–1163. 17886233
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Hum Genet. 2007;81: 559–575. doi: 10.1086/51979517701901
26. Bowden J, Davey Smith G, Burgess S, Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44: 512–525. doi: 10.1093/ije/dyv08026050253
27. Egger M, Davey Smith G, Schneider M, Minder C, Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315: 629–634. doi: 10.1136/bmj.316.7129.4699310563
28. Bowden J, Davey Smith G, Haycock PC, Burgess S, Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40: 304–314. doi: 10.1002/gepi.2196527061298
29. Huckins LM, Boraska V, Franklin CS, Floyd JAB, Southam L, Sullivan PF, et al. Using ancestry-informative markers to identify fine structure across 15 populations of European origin. Eur J Hum Genet. 2014;22: 1190–1200. doi: 10.1038/ejhg.2014.124549058
30. Mokry LE, Ross S, Ahmad OS, Forgetta V, Davey Smith G, Leong A, et al. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. PLoS Med. 2015;12: e1001866. doi: 10.1371/journal.pmed.100186626305103
31. Burgess S, Butterworth A, Thompson SG, Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37: 658–665. doi: 10.1002/gepi.2175824114802
32. Dastani Z, Hivert M-FF, Timpson NJ, Perry JRB, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8: e1002607. doi: 10.1371/journal.pgen.100260722479202
33. Patsopoulos NA, Evangelou E, Ioannidis JPA, Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008;37: 1148–1157. doi: 10.1093/ije/dyn06518424475
34. DerSimonian R, Laird N, Meta-analysis in clinical trials. Control Clin Trials. 1986;7: 177–188. 3802833
35. Patsopoulos NA, De Bakker PIW, Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol. 2011;70: 897–912. doi: 10.1002/ana.2260922190364
36. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014;46: 1173–1186. doi: 10.1038/ng.309725282103
37. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN, Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008;8: 200. doi: 10.1186/1471-2458-8-20018533989
38. Ahrens W, Pigeot I, Pohlabeln H, De Henauw S, Lissner L, Molnar D, et al. Prevalence of overweight and obesity in European children below the age of 10. Int J Obes. 2014;38: S99–S107.
39. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006;13: 700–722. 16834700
40. WHO. Body mass index—BMI. [cited 3 Dec 2015]. http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi
41. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384: 766–781. doi: 10.1016/S0140-6736(14)60460-824880830
42. Ogden CL, Carroll MD, Kit BK, Flegal KM, Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311: 806–814. doi: 10.1001/jama.2014.73224570244
43. Flegal KM, Carroll MD, Kit BK, Ogden CL, Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307: 491–497. doi: 10.1001/jama.2012.3922253363
44. Orton S-M, Herrera BM, Yee IM, Valdar W, Ramagopalan S V, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006;5: 932–936. doi: 10.1016/S1474-4422(06)70581-617052660
45. Koch-Henriksen N, Sørensen PS, The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9: 520–532. doi: 10.1016/S1474-4422(10)70064-820398859
46. Bays HE, Chapman RH, Grandy S, The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61: 737–747. doi: 10.1111/j.1742-1241.2007.01336.x17493087
47. Lamon-Fava S, Wilson PWF, Schaefer EJ, Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 1996;16: 1509–1515. 8977456
48. CDC. Diabetes Public Health Resource. In: Mean and Median Age at Diagnosis of Diabetes Among Adult Incident Cases Aged 18–79 Years, United States, 1997–2011. 2015 [cited 21 Apr 2016]. http://www.cdc.gov/diabetes/statistics/age/fig2.htm
49. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125: e2–e220. doi: 10.1161/CIR.0b013e31823ac04622179539
50. Degenhardt A, Ramagopalan S V, Scalfari A, Ebers GC, Clinical prognostic factors in multiple sclerosis: a natural history review. Nat Rev Neurol. 2009;5: 672–682. doi: 10.1038/nrneurol.2009.17819953117
51. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10: e1001383. doi: 10.1371/journal.pmed.100138323393431
52. Rotondi M, Batocchi AP, Coperchini F, Caggiula M, Zerbini F, Sideri R, et al. Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion. Neuroimmunomodulation. 2013;20: 341–347. doi: 10.1159/00035356724008588
53. Emamgholipour S, Eshaghi SM, Hossein-nezhad A, Mirzaei K, Maghbooli Z, Sahraian MA, Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease. PLoS ONE. 2013;8: e76555. doi: 10.1371/journal.pone.007655524098530
54. Musabak U, Demirkaya S, Genç G, Ilikci RS, Odabasi Z, Serum Adiponectin, TNF-α, IL-12p70, and IL-13 Levels in Multiple Sclerosis and the Effects of Different Therapy Regimens. Neuroimmunomodulation. 2011;18: 57–66. doi: 10.1159/00031739320714168
55. Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci U S A. 2005;102: 5150–5155. doi: 10.1073/pnas.040899510215788534
56. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H, Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323: 630–635. doi: 10.1016/j.bbrc.2004.08.14515369797